PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Marketing
Off-Label Comments Online: Keep Doing What You're Doing, Says FDA
Those in favor of a less is more approach to FDA social media guidelines got what they wanted for the holidays: a trim, 15-page document on how to respond to unsolicited off-label comments
Also posted in Advertising, E-Media, FDA, Legal, Regulatory, Technology, compliance, social media Tagged FDA Leave a comment
Why the Delay on Facts Boxes?
Despite a near-complete absence of criticism coming from industry, academia, clinicians and patients, the drug facts box – a concise, quantitative, easy-to-read format for presenting a drug’s risk/benefit profile in print advertisements – seems at least three years away from launch.
Also posted in Advertising, FDA, Legal, Regulatory, Strategy, patient education Tagged facts box 1 Comment
Pfizer CEO: DTC a 'Fundamental Right'
Direct-to-consumer (DTC) advertising is a “fundamental right in the U.S.,” and denying the right of industry to speak directly to patients through drug advertising “leads to ignorance and the inability to judge,” said Ian Read, Pfizer’s president and CEO, at the Cleveland Clinic on Tuesday.
Asked whether DTC ads on television should be retired, Read answered [...]
Also posted in Advertising, IP, Patient Communication, Regulatory, Strategy, leadership, patient education Tagged DTC, Pfizer CEO 7 Comments
Value Isn't Just Dollars and Cents, says Pfizer Exec
Now that 90% of the top 43 countries for drug sales have instituted “significant” cost containment measures, it’s more important than ever to give payers the rest of the story, according to a Pfizer executive.
Also posted in Europe, Global, Market Access, Patient Communication, Strategy, healthcare, pricing Tagged reimbursement Leave a comment
Genentech Runs Voluntary Corrective Ads for Boniva